AMR Industry Alliance formed to ensure pharma involvement in addressing antimicrobial resistance
CIDRAP News: Pharma leaders announce alliance to fight antimicrobial resistance
“An international association of pharmaceutical, biotechnology, and diagnostics companies [Thursday] announced the formation of a new alliance to monitor and drive industry efforts to fight antimicrobial resistance (AMR). The AMR Industry Alliance aims to bring together stakeholders from the life sciences industry to ensure progress is made on their commitments to reduce the development of antimicrobial resistance, invest in research and development, and improve global access to antimicrobials, diagnostic tests, and vaccines…” (Dall, 5/18).
Devex: New drug industry alliance will tackle antibiotic resistance
“…The initiative is being launched on the back of recent commitments, including the Industry Declaration on AMR and subsequent Roadmap, which were signed by more than 100 companies and trade associations during meetings at last year’s World Economic Forum and a high-level United Nations meeting on AMR. The commitments set out a plan for global action to reduce AMR through investing in research and development, [and] improving access to antibiotics, vaccines, and diagnostics…” (Edwards, 5/19).